Although ZDHHC2 promotes enzalutamide resistance in prostate cancer, the underlying mechanisms remain to be elucidated, so multi‐omics analyses were performed with control and ZDHHC2 knockdown C4‐2 cell lines (Figure 3A). This evidence concerns the gene ZDHHC2 and Familial prostate cancer.